Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica, Strain 78-9159

675 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica, Strain 78-9159. See the species affected, top reactions, and outcomes below.

675
adverse-event reports
11.7%
death-coded share
Dog
most-reported species
279
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
675
Total Reports
79
Deaths Reported
11.7%
Death Rate

Active Ingredients

Bordetella Bronchiseptica, Strain 78-9159

Administration Routes

SubcutaneousUnknownNasalOralIntravenous

Species Affected

Dog 675

Most Affected Breeds

Terrier - Bull - American Pit 50
Retriever - Labrador 46
Retriever - Golden 34
Boxer (German Boxer) 34
Terrier - Yorkshire 27
Chihuahua 27
Crossbred Canine/dog 26
Shih Tzu 23
Shepherd Dog - Australian 20
Terrier (unspecified) 19

Most Reported Reactions

Vomiting 279
Lethargy (see also Central nervous system depression in 'Neurological') 143
Facial swelling (see also 'Skin') 119
Anaphylaxis 105
Hives (see also 'Skin') 94
Diarrhoea 83
Pale mucous membrane 64
Fever 54
Lethargy (see also Central nervous system depression in Neurological) 44
Panting 42
Anorexia 40
Death 39

Outcome Breakdown

Ongoing
340 (50.2%)
Recovered/Normal
223 (32.9%)
Died
44 (6.5%)
Euthanized
35 (5.2%)
Outcome Unknown
34 (5.0%)
Recovered with Sequela
1 (0.1%)

Bordetella Bronchiseptica, Strain 78-9159 Adverse Event Insights

675 reports name Bordetella Bronchiseptica, Strain 78-9159; 79 recorded a death outcome (11.7% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica, Strain 78-9159. Administration routes: Subcutaneous, Unknown, Nasal, Oral.

By species: Dog (675 reports). By breed: Terrier - Bull - American Pit (50), Retriever - Labrador (46), Retriever - Golden (34).

Leading clinical signs: Vomiting (279), Lethargy (see also Central nervous system depression in 'Neurological') (143), Facial swelling (see also 'Skin') (119), Anaphylaxis (105). Outcome, 677 coded reports: Ongoing leads at 50.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.